13F-HR filed by Deep Track Capital, LP
Deep Track Capital, LP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 58 holding rows worth $2,434,834,304.
- Accession
- 0001856083-23-000002
- Filer
- CIK 1856083
- Filed
- 2023-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 58 entries on the cover page, a total value of $2,434,834,304 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,434,834,304 with VALUE read as dollars as filed, 13F file number 028-21949. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 1,200,000 | $175,596,000 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 6,500,000 | $158,145,000 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 6,147,268 | $138,252,057 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 7,432,717 | $115,281,441 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 6,500,000 | $110,825,000 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 2,834,069 | $101,289,626 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 1,700,000 | $92,055,000 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 3,422,057 | $91,026,716 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 3,000,000 | $84,570,000 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 3,100,000 | $79,794,000 | dollars as filed | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 3,000,000 | $69,450,000 | dollars as filed | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 729,000 | $66,280,680 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 3,187,415 | $64,003,293 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 2,646,782 | $62,966,936 | dollars as filed | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 6,350,000 | $62,293,500 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 2,819,045 | $59,961,087 | dollars as filed | |
| GERON CORP | 374163103 | COM | 26,867,479 | $58,302,429 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 200,000 | $55,606,000 | dollars as filed | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 1,600,000 | $45,840,000 | dollars as filed | |
| AGENUS INC | 00847G705 | COM NEW | 30,000,000 | $45,600,000 | dollars as filed | |
| SEAGEN INC | 81181C104 | COM | 217,800 | $44,097,966 | dollars as filed | put |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 3,504,390 | $40,580,836 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 2,278,107 | $39,160,659 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 1,250,000 | $38,275,000 | dollars as filed | |
| EXELIXIS INC COM | 30161Q104 | Stock | 1,931,874 | $37,497,674 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 100,000 | $37,258,000 | dollars as filed | put |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,230,259 | $31,297,789 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 15,000,000 | $27,600,000 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 1,800,000 | $27,414,000 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,334,633 | $26,894,972 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 2,727,606 | $26,839,643 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 2,997,830 | $26,620,730 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 704,533 | $26,257,945 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 1,816,531 | $24,159,862 | dollars as filed | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 1,363,201 | $21,061,455 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 3,068,259 | $20,465,288 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 2,025,137 | $19,826,091 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 3,250,000 | $18,622,500 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 865,767 | $17,436,547 | dollars as filed | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 2,345,073 | $17,048,681 | dollars as filed | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 3,952,000 | $16,045,120 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 3,585,000 | $15,953,250 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,708,971 | $13,825,575 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 7,720,688 | $12,816,342 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 1,951,580 | $12,099,796 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 571,233 | $10,482,126 | dollars as filed | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 4,259,653 | $7,880,358 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 2,837,818 | $6,413,469 | dollars as filed | |
| ORCHARD THERAPEUTICS PLC | 68570P200 | ADR | 1,166,670 | $6,265,018 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 3,234,722 | $4,884,430 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 1,354,200 | $4,807,410 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 499,400 | $3,990,206 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 2,524,242 | $3,761,121 | dollars as filed | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 350,000 | $3,570,000 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 1,022,892 | $3,549,435 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 428,100 | $1,643,904 | dollars as filed | put |
| NEKTAR THERAPEUTICS | 640268108 | COM | 1,743,248 | $1,225,329 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 4,400 | $67,012 | dollars as filed | put |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001856083-23-000002 | this filing | 2023-05-15 | acceptance time not in the bulk data set |